You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mountain cedar

Showing 1 - 25 of 569
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allergic Rhinitis Due to Tree Pollen, Allergic Conjunctivitis, Allergic Rhinoconjunctivitis Trial in Austin, Grapevine, San

Completed
Has Results
  • Allergic Rhinitis Due to Tree Pollen
  • +2 more
  • Intra-lymphatic allergenic extract
  • Intra-lymphatic placebo
  • Austin, Texas
  • +2 more
Mar 29, 2021

Seasonal Allergic Rhinitis Trial in Irvine (Bepotastine besilate, Placebo)

Completed
Has Results
  • Seasonal Allergic Rhinitis
  • Bepotastine besilate
  • Placebo
  • Irvine, California
    Bausch & Lomb Incorporated
Oct 1, 2020

Anxiety Generalized Trial in Lauderhill (MM-120, Placebo)

Recruiting
  • Anxiety Generalized
  • MM-120 (LSD D-Tartrate)
  • Placebo
  • Little Rock, Arkansas
  • +15 more
Jan 27, 2023

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

Active, not recruiting
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Ipilimumab
  • Nivolumab
  • Auburn, California
  • +205 more
Oct 18, 2022

Osteoarthritis, Knee, Diabetic Neuropathic Pain, Chronic Low-back Pain Trial in Puerto Rico, United States (LY3016859 ISA,

Recruiting
  • Osteoarthritis, Knee
  • +2 more
  • LY3016859 ISA
  • +5 more
  • Hamden, Connecticut
  • +38 more
Aug 14, 2023

Diabetic Peripheral Neuropathic Pain Trial in Puerto Rico, United States (LY3526318, Placebo)

Recruiting
  • Diabetic Peripheral Neuropathic Pain
  • Chandler, Arizona
  • +35 more
Aug 17, 2022

Diabetic Peripheral Neuropathic Pain Trial in Puerto Rico, United States (LY3556050, Placebo)

Terminated
  • Diabetic Peripheral Neuropathic Pain
  • Chandler, Arizona
  • +36 more
Jul 27, 2022

Advanced Malignant Solid Tumor, Anorexia, Hematopoietic and Lymphoid Cell Tumor Trial in United States (Olanzapine, Megestrol

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Englewood, Colorado
  • +67 more
Jan 11, 2022

Hematopoietic and Lymphoid Cell Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Puerto Rico,

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Educational Intervention
  • +3 more
  • Fairbanks, Alaska
  • +152 more
Mar 29, 2022

Tumors With Aberrations in ALK or ROS1 Trial in United States (Ceritinib)

Terminated
Has Results
  • Tumors With Aberrations in ALK or ROS1
  • Santa Rosa, California
  • +20 more
Mar 12, 2021

Amorphous, Eosinophilic, and Acellular Deposit, Constipation, Diarrhea Trial in United States (Isatuximab, Laboratory Biomarker

Active, not recruiting
  • Amorphous, Eosinophilic, and Acellular Deposit
  • +12 more
  • Isatuximab
  • Laboratory Biomarker Analysis
  • Anchorage, Alaska
  • +344 more
Aug 22, 2022

Improving Adolescent and Young Adult Self-Reported Data in

Recruiting
  • Breast Cancer, NOS
  • +11 more
  • Questionnaires
  • Fairbanks, Alaska
  • +313 more
Sep 20, 2022

CD20 Positive, Mantle Cell Lymphoma Trial in United States (procedure, other, biological)

Recruiting
  • CD20 Positive
  • Mantle Cell Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Birmingham, Alabama
  • +318 more
Jan 3, 2023

Palbociclib in Real World Practice

Recruiting
  • Advanced Breast Cancer
  • Metastatic Breast Cancer
  • non-interventional
  • Alabaster, Alabama
  • +304 more
Oct 10, 2022

Prostate Cancer Trial in United States (TAK-700, Bicalutamide)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Birmingham, Alabama
  • +559 more
Dec 5, 2022

KRAS Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • KRAS Gene Mutation
  • +2 more
  • Anchorage, Alaska
  • +604 more
Jan 28, 2023

DLBCL, Follicular Lymphoma Trial in United States (Epcoritamab)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • Fountain Valley, California
  • +38 more
Jul 27, 2022

Prostate Cancer Trial in United States (bicalutamide, goserelin, mitoxantrone HCl)

Completed
Has Results
  • Prostate Cancer
  • Anchorage, Alaska
  • +233 more
Dec 5, 2022

Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in United States (Bendamustine

Suspended
  • Grade 1 Follicular Lymphoma
  • +4 more
  • Bendamustine Hydrochloride
  • +13 more
  • Anchorage, Alaska
  • +422 more
Feb 2, 2023

Cancer Care Delivery in Adolescent and Young Adult Acute

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Discussion
  • +2 more
  • Anchorage, Alaska
  • +481 more
Jan 25, 2023

Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United

Active, not recruiting
Has Results
  • Chronic Myelomonocytic Leukemia
  • +6 more
  • Birmingham, Alabama
  • +297 more
Jan 28, 2023

Desmoplastic Melanoma Trial in United States (Pembrolizumab, Therapeutic Conventional Surgery)

Active, not recruiting
  • Desmoplastic Melanoma
  • Pembrolizumab
  • Therapeutic Conventional Surgery
  • Fairbanks, Alaska
  • +282 more
Jun 28, 2022

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in United States (Bosutinib, Dasatinib, Laboratory Biomarker

Active, not recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Anchorage, Alaska
  • +540 more
Dec 14, 2022

Human Papillomavirus Trial in United States (Alinity m HR HPV)

Active, not recruiting
  • Human Papillomavirus
  • Alinity m HR HPV
  • Birmingham, Alabama
  • +56 more
Jul 26, 2022

Diabetes, Type 2 Trial in United States (Gan & Lee Insulin Glargine Injection, Lantus®)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Gan & Lee Insulin Glargine Injection
  • Lantus®
  • Birmingham, Alabama
  • +56 more
Mar 23, 2022